ArticlePharmaceuticals (Basel, Switzerland)2022

Associations of Plasma Concentration Profiles of Dapagliflozin, a Selective Inhibitor of Sodium-Glucose Co-Transporter Type 2, with Its Effects in Japanese Patients with Type 2 Diabetes Mellitus.

Tetsuo Hayakawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.